Article info

Original research
Association of bridging therapy utilization with clinical outcomes in patients receiving chimeric antigen receptor (CAR) T-cell therapy

Authors

  1. Correspondence to Dr P Connor Johnson; pcjohnson{at}mgh.harvard.edu
View Full Text

Citation

Johnson PC, Jacobson C, Yi A, et al
Association of bridging therapy utilization with clinical outcomes in patients receiving chimeric antigen receptor (CAR) T-cell therapy

Publication history

  • Accepted July 30, 2022
  • First published September 9, 2022.
Online issue publication 
September 09, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.